UBS AM
MTEM

UBS AM’s Molecular Templates, Inc. MTEM Stock Holding History

UBS AM’s Portfolio MTEM Stock Details MTEM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-1,875
Closed -$189K – 2916
2021
Q3 		$189K Hold
1,875
– – ﹤0.01% 2695
2021
Q2 		$220K Buy
1,875
+1,128
+151% +$148K ﹤0.01% 2700
2021
Q1 		$141K Sell
747
-740
-50% -$130K ﹤0.01% 2582
2020
Q4 		$209K Buy
1,487
+747
+101% +$110K ﹤0.01% 2492
2020
Q3 		$121K Buy
740
+60
+9% +$10.7K ﹤0.01% 2453
2020
Q2 		$141K Buy
+680
New +$158K ﹤0.01% 2432
2015
Q4 		– Sell
-11,798
Closed -$7.92M – 2721
2015
Q3 		$7.92M Hold
11,798
– – 0.01% 921
2015
Q2 		$7.86M Hold
11,798
– – 0.01% 957
2015
Q1 		$7.9M Hold
11,798
– – 0.01% 941
2014
Q4 		$6.19M Hold
11,798
– – 0.01% 990
2014
Q3 		$7.03M Buy
11,798
+517
+5% +$358K 0.01% 957
2014
Q2 		$7.37M Hold
11,281
– – 0.01% 941
2014
Q1 		$8.86M Buy
11,281
+277
+3% +$225K 0.01% 887
2013
Q4 		$8.48M Hold
11,004
– – 0.01% 870
2013
Q3 		$8.44M Buy
11,004
+199
+2% +$164K 0.01% 848
2013
Q2 		$9.38M Buy
+10,805
New +$9.14M 0.01% 786

Other funds holding MTEM

BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
PAMS
Pictet Asset Management (Switzerland) Geneva 73, Switzerland $84.3B AUM 26.5% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CC
Caxton Corporation Princeton, New Jersey $4.02M AUM 256.08% 1-Year Est. Return
FM
Frazier Management Seattle, Washington $1.12M AUM 151.58% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
KCM
Kingdon Capital Management New York $911M AUM 51.11% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

UBS AM's MTEM Position: Q4 2021 in Review

UBS AM sold out of Molecular Templates, Inc. (MTEM) in Q4 2021, closing a stake of 1,875 shares — an estimated $189K sold.

UBS AM first reported a position in MTEM in Q2 2013 and held it in 16 quarters. The position peaked at $9.38M in Q2 2013. 79 funds tracked by Wall St. Rank hold MTEM as of Q4 2021.

  • UBS AM reported no remaining Molecular Templates, Inc. position as of Q4 2021 after selling out during the quarter.
  • UBS AM sold 1,875 Molecular Templates, Inc. shares in Q4 2021, an estimated $189K.
  • UBS AM first reported a position in Molecular Templates, Inc. in Q2 2013 and held it in 16 quarters.
  • UBS AM's Molecular Templates, Inc. position peaked at $9.38M in Q2 2013.
  • 79 funds tracked by Wall St. Rank held Molecular Templates, Inc. as of Q4 2021.

Based on UBS AM's 13F filing for Q4 2021, filed 14 Feb 2022.